Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Disease area: Airway diseases

Abstract

Introduction: T helper 2 (Th2) lymphocytes play an important role in chronic inflammatory process of allergic disease. IL-33 targeting ST2 receptor selectively expressed on Th2 cells surface, regulates the production of cytokines as IL-17A and IL-31.Aim: To evaluate the role of IL-33/ST2 axis in the IL-31 and IL-17 production during systemic inflammation of patients with allergic rhinitis (AR) and concomitant allergic asthma and rhinitis (AAR) compared to healthy control subjects (HC).Methods: 20 HC, 14 AR and 17 AAR subjects were recruited and blood samples collected. IL-31, IL-33, and IL-17A plasma concentrations were measured by commercial ELISA. IL-17A and IL-31 production, and ST2 receptor expression were evaluated by flow-cytometric analysis in PBMC from HC, AR, AAR (n=6 for each group). Finally, the in vitro activity of Beclomethasone Dipropionate (BDP) (10^-8M to 10^-7M) was evaluated on IL-17A and IL-31 production, together with ST2 receptor expression in PBMC from AAR (n=6).Results: IL-17A, IL-31 and IL-33 plasma levels were significantly higher in patients with AR and AAR than in HC. IL-31 and IL-17A intracellular levels significantly increased in PBMC from AR and AAR compared to HC while ST2 receptor expression was significantly lower. Finally, IL-17A and IL-31 intracellular levels were decreased by BDP treatment, while ST2 receptor expression increased in cultured PBMCs from AAR.Conclusions: IL-33/ST2 axis activation is a biomarker of Th2/IL-31 and Th17 immune response in the allergic airway disease. Finally, a potential therapeutic approach by BDP might be useful treatment to control Th2/IL-31 and Th17 immune response, in patients with concomitant allergic asthma and rhinitis.

Rating:

Share or cite this content

Citations should be made in the following way:
L. Vocca, A. Sala, S. Gangemi, C. Di Sano, L. Riccobono, C. Uasuf, G. Anzalone, A. Bonanno, R. P. Gagliardo, M. Profita (Palermo, Milan, Messina, Italy). Role of IL-33/ST2 axis in systemic inflammation of allergic airway disease. Eur Respir J 2014; 44: Suppl. 58, 3876

Member's Comments

No comment yet.

Related content which might interest you: Disturbed pulmonary immunity and the phenotype of alveolar macrophages in bronchial asthma, gastroesophageal reflux disease and their combination Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease Source: International Congress 2014 – Cell biology 2014 Year: 2014 Implication of IL-18 in the chronic inflammation of severe refractory asthma Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Association between airway inflammation, airway remodelling and physiological changes in asthma Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Serum periostin in obstructive airways disease: Range, relationships and response to corticosteroid Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients Source: International Congress 2014 – Translational studies in COPD Year: 2014 Adult asthma patients reporting exacerbations triggered by upper airway infection have increased total IgE and sensitization to HDM Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Differential bronchoalveolar expression of candidate microRNAs in chronic obstructive pulmonary disease, asthma bronchiale and pulmonary sarcoidosis Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine Year: 2014 Effects of aerobic training on perivascular inflammation and on vascular activation in a model of asthma Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Autoimmunity  in airway inflammation and asthma Source: International Congress 2017 – GR3 Scientific Grand Round: Autoimmunity in chronic lung disease Year: 2017 The airway microbiota is significantly altered in subjects with eosinophilic asthma Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Tiotropium effects on airway inflammatory events in the cat as an animal model for acute cigarette smoke-induced lung inflammation Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Airway remodeling and eosinophilic asthma Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 The U-BIOPRED severe asthma study: Immunopathological characterisation Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Alveolar macrophages phenotype in patients with asthma and its combination with gastroesophageal reflux disease with pulmonary manifestations Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Importance of concomitant local and systemic eosinophilia in uncontrolled asthma Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 25-hydroxyvitamin D promotes the long-term effects of specific immunotherapy (SIT) in allergic airway inflammation in mice Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Modulation of neutrophil functionalities by indacaterol and their relevance for chronic lung diseases Source: International Congress 2014 – Translational studies in COPD Year: 2014 Induced sputum and bronchial hyperresponsiveness in COPD patients Source: International Congress 2014 – Airway biomarkers Year: 2014